• SLT is a therapy (Rx), and not a surgical treatment – it is gentle, does not destroy tissue and can be repeated.
• There are no risks, few complications and side effects are minimal.
  
• At least one in three glaucoma patients will benefit from SLT.
  
• It should not be confused with or compared to argon laser trabeculoplasty (ALT), which causes permanent damage to the structure of the TM. Unlike ALT, SLT can be repeated as needed.
  
• SLT can be used as a primary treatment for patients who are known to be non-compliant with medication (due to problems of literacy, lifestyle and mental or physical challenges).
  
• It can be used as a primary treatment or a replacement treatment if medication is not well tolerated.
  
• SLT is not designed to replace medication, but it can help to reduce the number of drugs taken.
  
• SLT is a slit lamp-based, simple, in-office procedure.
  
• However, SLT is not a miracle cure. Patients who have been on multiple medications for a long period of time, patients with (pseudo ex) syndrome or pigmentary glaucoma may require extra care and attanetion.

There is a growing body of experience and evidence demonstrating the benefits of SLT. To review current literature and clinical tips, click here.